Is there no place like home for an allogeneic stem cell transplant?

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Gutiérrez-García G, Rovira M, Arab N, Gallego C, Sánchez J, Álvarez MÁ, et al. A reproducible and safe at-home allogeneic haematopoietic cell transplant program: first experience in central and Southern Europe. Bone Marrow Transplant.

  2. 2.

    Niederwieser D, Baldomero H, Szer J, Gratwohl M, Aljurf M, Atsuta Y, et al. Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey. Bone Marrow Transpl. 2016;51:778–85.

  3. 3.

    Aljurf M, Weisdorf D, Hashmi S, Nassar A, Gluckman E, Mohty M, et al. Worldwide network for blood and marrow transplantation recommendations for establishing a hematopoietic stem cell transplantation program in countries with limited resources, Part II: clinical, technical, and socioeconomic considerations. Biol Blood Marrow Transpl. 2019;25:2330–7.

  4. 4.

    Von AhD, Spath M, Nielsen A, Fife B. The Caregiver’s role across the bone marrow transplantation trajectory. Cancer Nurs. 2016;39:E2–9.

  5. 5.

    Grimm PM, Zawacki KL, Mock V, Krumm S, Frink BB. Caregiver responses and needs. An ambulatory bone marrow transplant model. Cancer Pract. 2000;8:120–8.

  6. 6.

    Luznik L, O’Donnell PV, Symons HJ, Chen AR, Leffell MS, Zahurak M, et al. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biol Blood Marrow Transpl. 2008;14:641–50.

  7. 7.

    Martino M, Ciavarella S, De Summa S, Russo L, Meliambro N, Imbalzano L, et al. A comparative assessment of quality of life in patients with multiple myeloma undergoing autologous stem cell transplantation through an outpatient and inpatient model. Biol Blood Marrow Transpl. 2018;24:608–13.

  8. 8.

    Dix SP, Geller RB. High-dose chemotherapy with autologous stem cell rescue in the outpatient setting. Oncology 2000;14:171–85.

  9. 9.

    Guru Murthy GS, Hari PN, Szabo A, Pasquini M, Narra R, Khan M, et al. Outcomes of reduced-intensity conditioning allogeneic hematopoietic cell transplantation performed in the inpatient versus outpatient setting. Biol Blood Marrow Transpl. 2019;25:827–33.

  10. 10.

    Rizzo JD, Vogelsang GB, Krumm S, Frink B, Mock V, Bass EB. Outpatient-based bone marrow transplantation for hematologic malignancies: cost saving or cost shifting? J Clin Oncol. 1999;17:2811–8.

  11. 11.

    Hayes-Lattin B, Leis JF, Maziarz RT. Isolation in the allogeneic transplant environment: how protective is it? Bone Marrow Transpl. 2005;36:373–81.

Download references

Author information

Correspondence to Jeff Szer.

Ethics declarations

Conflict of interest

The author declares that he has no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Szer, J. Is there no place like home for an allogeneic stem cell transplant?. Bone Marrow Transplant (2020). https://doi.org/10.1038/s41409-020-0828-2

Download citation